Logo image of ORMP

ORAMED PHARMACEUTICALS INC (ORMP) Stock Analyst Ratings

NASDAQ:ORMP - Nasdaq - US68403P2039 - Common Stock - Currency: USD

2  -0.09 (-4.31%)

After market: 2.01 +0.01 (+0.5%)

Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to ORMP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.32. This target is 65.75% above the current price.
ORMP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ORMP.
In the previous month the buy percentage consensus was at a similar level.
ORMP was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

ORMP Historical Analyst RatingsORMP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -96 -87 -78 -69 -60 -51 -42 -33 -24 -15 -6 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.003.283.323.323.41 - 64.13% 65.75% 65.75% 70.63%

Related screens

ORMP Current Analyst RatingORMP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2024-09-09 HC Wainwright & Co. Reiterate Neutral
2024-05-20 HC Wainwright & Co. Reiterate Neutral
2023-05-17 Canaccord Genuity Maintains Hold -> Hold
2023-01-17 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-01-12 Canaccord Genuity Downgrade Buy -> Hold
2022-05-16 Aegis Capital Maintains Buy
2022-02-18 Cantor Fitzgerald Initiate Overweight
2021-11-30 HC Wainwright & Co. Maintains Buy
2021-11-29 HC Wainwright & Co. Maintains Buy
2021-11-02 Aegis Capital Maintains Buy
2021-07-29 Canaccord Genuity Maintains Buy
2021-06-08 Aegis Capital Maintains Buy
2021-04-20 Canaccord Genuity Initiate Buy
2021-02-09 National Securities Corporation Initiate Buy